Acta Scientiae Veterinariae ISSN: Universidade Federal do Rio Grande do Sul Brasil

Similar documents
OCCURRENCE OF CAMPYLOBACTER JEJUNI AND CAMPYLOBACTER COLI AND THEIR BIOTYPES IN BEEF AND DAIRY CATTLE FROM THE SOUTH OF CHILE

Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin

Preliminary investigation of antibiotic resistant and susceptible Campylobacter in retail ground beef in the United States.

BRIEF COMMUNICATION ABSTRACT

DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme

Campylobacter spp. and Related Organisms in Poultry

ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED

ANTIMICROBIAL RESISTANCE IN COMMENSAL E. COLI FROM LIVESTOCK IN BELGIUM: Veterinary Epidemiology

Project Summary. Emerging Pathogens in US Cattle

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco

ARCH-Vet. Summary 2013

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Incidence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli in broiler flocks in the Czech Republic

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

Ciprofloxacin and azithromycin resistance of Campylobacter spp isolated from international travellers,

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Antimicrobial Resistance: Do we know everything? Dr. Sid Thakur Assistant Professor Swine Health & Production CVM, NCSU

Christiane Gaudreau* and Huguette Gilbert

On farm risks associated with the prevalence of resistant strains of Escherichia coli: a pilot study

Susceptibility testing of Salmonella and Campylobacter

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Origins of Resistance and Resistance Transfer: Food-Producing Animals.

Frank Møller Aarestrup

Antimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali,

Neisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE

Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017

The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli

EFSA s activities on Antimicrobial Resistance

AGISAR Pilot Project on Integrated Surveillance of AMR in Uganda

ANTIBIOTIC SENSITIVITY PATTERN OF YERSINIA ENTEROCOLITICA ISOLATED FROM MILK AND DAIRY PRODUCTS*

What s new in EUCAST methods?

Prevalence of Campylobacter jejuni and Campylobacter coli species in cats and dogs from Bydgoszcz (Poland) region

UDC: : :579.22/ :615.28

Prevalence of Campylobacter spp. in Nigerian Indigenous Chicken in Sokoto State Northwestern Nigeria.

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

CRISPR Diversity and Antimicrobial Susceptibility of Salmonella Isolates from Dairy Farm Environments in Texas

Campylobacter infections in EU/EEA and related AMR

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

International Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals

Antibiogram of Dermatophilus congolensis Isolates from Cattle

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

Emergence and predominance of a hypervirulent, tetracyclineresistant. clone as a major cause of sheep abortion in the United States

EPIDEMIOLOGY OF CAMPYLOBACTER IN IRELAND

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

ZOONOSES MONITORING. Luxembourg IN 2014 TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

Nova Journal of Medical and Biological Sciences Page: 1

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

CROATIA TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN HUMANS, FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS

Please distribute a copy of this information to each provider in your organization.

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections

Presence of extended spectrum β-lactamase producing Escherichia coli in

The Report referred to in Article 5 of Directive 92/117/EEC

Background and Plan of Analysis

University Ss Cyril and Methodius in Skopje Faculty of veterinary medicine-skopje

Comparison of Antimicrobial Resistance of Campylobacter jejuni and Campylobacter coli Isolated from Humans and Chicken Carcasses in Poland

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Animal Antibiotic Use and Public Health

Integrated Analysis of Data on Resistance and Antimicrobial Consumption from the Human and Animal Sectors in Europe The JIACRA Report

Prevalence and Antibiotics Resistance of Campylobacter jejuni in Retail Chickens in Oyo State, Nigeria

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014

FACT SHEETS. On the Danish restrictions of non-therapeutical use of antibiotics for growth promotion and its consequences

The Report referred to in Article 9 of Directive 2003/ 99/ EC

Short information about the ZOBA. Participating on proficiency tests. Monitoring programme

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

Evaluation of antimicrobial activity of Salmonella species from various antibiotic

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

Campylobacter species

What do we know about multidrug resistant bacteria in New Zealand s pet animals?

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Tel: Fax:

European Committee on Antimicrobial Susceptibility Testing

Antimicrobial Stewardship Strategy: Antibiograms

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Monitoring gonococcal antimicrobial susceptibility

Antimicrobial Cycling. Donald E Low University of Toronto

Isolation and Characterization of Campylobacterjejuni and

2010 EU Summary Report on Zoonoses: overview on Campylobacter

Irrational use of antimicrobial agents often

Country Report: Malaysia

Antibiotic resistance of bacteria along the food chain: A global challenge for food safety

The Report referred to in Article 5 of Directive 92/117/EEC

Comparison of Antimicrobial Susceptibility Testing of Campylobacter spp. by the Agar Dilution and the Agar Disk Diffusion Methods

Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines

Antibiotic Susceptibility Pattern of Vibrio cholerae Causing Diarrohea Outbreaks in Bidar, North Karnataka, India

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Antimicrobial use in poultry: Emerging public health problem

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Transcription:

Acta Scientiae Veterinariae ISSN: 1678-0345 ActaSciVet@ufrgs.br Universidade Federal do Rio Grande do Sul Brasil Fernández, Heriberto; Oval, Andrés Occurrence of Campylobacter jejuni and Campylobacter coli Biotypes and Antimicrobial Susceptibility in Healthy Dogs in Southern Chile Acta Scientiae Veterinariae, vol. 41, núm. 1, enero-diciembre, 2013, pp. 1-5 Universidade Federal do Rio Grande do Sul Porto Alegre, Brasil Available in: http://www.redalyc.org/articulo.oa?id=289031817006 How to cite Complete issue More information about this article Journal's homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative

Acta Scientiae Veterinariae, 2013. 41: 1100. RESEARCH ARTICLE Pub. 1100 ISSN 1679-9216 Occurrence of Campylobacter jejuni and Campylobacter coli Biotypes and Antimicrobial Susceptibility in Healthy Dogs in Southern Chile Heriberto Fernández & Andrés Oval ABSTRACT Background: The thermotolerant species of Campylobacter, mainly C. jejuni and C. coli, are as important agents of human gastroenteritis worldwide, being a serious public health problem. They are widely distributed in the environment and the animal kingdom having as reservoirs a wide variety of animals, including dogs, which in turn can act as a source of infection for humans. The Campylobacter isolation rates found in dogs are heterogeneous with few available data in Latin American countries. However Campylobacter diarrhea in humans is a self-limited clinical process being antimicrobial treatment not always necessary, it is necessary to know their antimicrobial susceptibility/resistance profiles in clinical and reservoirs isolates, especially in C. jejuni and C. coli strains isolated from animals close to man as dogs are. The aims of this work were to determine the isolation frequency of C. jejuni and C. coli and their biotypes in healthy dogs and the susceptibility/resistance profiles of the isolated strains to six antimicrobial drugs. Materials, Methods & Results: Fecal samples from 141 healthy dogs were obtained, seeded into the TEC transport medium. In the laboratory, each sample was plated out on modified Skirrow medium and incubated at 42 C for 48 h under microaerobic conditions. The isolated strains were identified to species and biotype levels through their phenotypic characteristics using the API Campy procedure (biomérieux, Marcy/Etoile, France) and the method described by Lior, respectively. The antimicrobial susceptibility patterns to ampicillin, ciprofloxacin, chloramphenicol, erythromycin, gentamicin and tetracycline were determined by means of the E-test method, considering as the minimal inhibitory concentrations (MICs) the lowest antibiotic concentrations yielding no growth. Ampicillin resistant strains were tested for β-lactamase production with the chromogenic cephalosporin test and the disc diffusion susceptibility test for ampicillin-sulbactam. The recovery rate of Campylobacter was 31.2% (C. jejuni 22.7%, C. coli 8.5%). Three of the four biotypes described for C. jejuni and the two described for C. coli were fo und being C. jejuni biotype I the most frequent one (53.1%). None of the strains showed resistance to chloramphenicol, erythromycin, gentamicin and tetracycline. Resistant strains were found for ciprofloxacin (6 strains, 13.9%) and ampicillin (4 strains, 9.1%). All the ampicillin resistant strains were found to be ß-lactamase producers. Discussion: The Campylobacter isolation rate (31.2%) found is not negligible. It may provide an epidemiological insight about the risk of zoonotic infection for individuals maintaining contact with dogs, especially for children. Direct contact with pets is a risk factor for acquiring campylobacteriosis, which was also observed in Latin-American countries. Ampicillin resistance is related to ß-lactamase production and was reported in different countries, including Chile. Campylobacter resistance to quinolones has been increasingly reported in strains of human and animal origin, especially from animals related to husbandry. The ciprofloxacin resistant strains found in this study probably could be a reflection of their spread to human pets. Because dogs have been identified as a potential source of human Campylobacter infections, exposure to animals carrying fluoroquinolone-resistant microorganisms could be a risk factor for acquiring this kind of strains. Keywords: Campylobacter jejuni, Campylobacter coli, dogs, biotypes, antimicrobial resistance. Received: 20 April 2012 Accepted: 30 August 2012 Published: 3 January 2013 Instituto de Microbiología Clínica, Universidad Austral de Chile (UACh), Valdivia, Chile. CORRESPONDENCE: H. Fernández [hfernand@uach.cl - Fone: +56 (63) 214377] Instituto de Microbiología Clínica - UACh. Edificio de Ciencias Biomédicas, 2 Piso. Campus Isla Teja, Casila 567,Valdivia, Chile. 1

INTRODUCTION The thermotolerant species of Campylobacter, mainly C. jejuni and C. coli, are recognized as important agents of human gastroenteritis worldwide, representing a serious public health problem in industrialized and developing countries [7,12,25]. These species are widely distributed in the environment and the animal kingdom. Their zoonotic characteristics are important in explaining their epidemiological significance, especially if their natural reservoirs are a wide variety of animals, both domestic and free-living; which in turn can act as a source of infection for humans [7,10,12,25]. The dog is one of the domestic animals recognized as Campylobacter reservoirs [7,10,12,15,19,25]. In developing, as well as in industrialized countries, the Campylobacter isolation frequencies found in dogs are heterogeneous with few available data in Latin American countries [6,10,15,19]. In general, Campylobacter diarrhea in humans is a self-limited clinical process with antimicrobial treatment being not always necessary, which is recommended only when there are clinical complications [16,20,25]. However, it is necessary to know the behavior of these bacteria to antibiotics in both clinical and reservoirs isolates, especially in C. jejuni and C. coli strains isolated from animals very close to man as are domestic animals and pets, including dogs [16,20,25]. The aims of this work were to determine the frequency of isolation of C. jejuni and C. coli and their biotypes in healthy dogs in the city of Valdivia (Southern Chile) establishing the susceptibility/resistance profiles of the isolates to six antimicrobial drugs. MATERIALS AND METHODS In this research it were studied 141 apparently healthy dogs which were randomly selected, from those submitted by their owners for vaccination at the Valdivia Health Service Antirabies Vaccination Center (Valdivia City; 39 47 Southern latitude, 73 15 Western latitude). Animals that received antibiotics up to 30 days before sampling and those without a known owner, or even having one but presenting wandering habits, were considered as stray dogs and were not admitted in the study. A fecal sample was taken from each animal by means of a rectal swab. Each sample was identified with an appropriate code number and seeded into the TEC transport medium [5] and transported to the laboratory. Samples were plated out on modified Skirrow agar plates, which were incubated at 42 C for 48 h under microaerobic conditions [3]. The identification of the species was done with phenotypic tests using the API Campy procedure 1. The biotyping was done using the method described by Lior [14] as adapted for use in our laboratory [3]. The antimicrobial susceptibility patterns of the isolated strains to ampicillin, ciprofloxacin, chloramphenicol, erythromycin, gentamicin and tetracycline were determined by means of the E-test method 1, previously used in our laboratory for testing Arcobacter butzleri [22]. Minimal inhibitory concentrations (MICs) were defined as the lowest antibiotic concentrations yielding no growth. The ampicillin resistant strains were tested for beta lactamase production with the chromogenic cephalosporin test [21] and the disc diffusion susceptibility test for ampicillin-sulbactam [13]. RESULTS As showed in Table 1, from the 141 dogs studied, 44 (31.2%) showed positive cultures for Campylobacter. The isolated species were C. jejuni [32 (22.7%)] and C. coli [12 (8.5%)]. All the 44 Campylobacter strains were amenable for biotyping. Three of the four biotypes described by Lior [14] for C. jejuni and the two biotypes described for C. coli were found (Table 1). Table 1. Isolation rates of Campylobacter jejuni and Campylobacter coli biotypes in fecal samples from 141 healthy dogs. BIOTYPES ISOLATED SPECIES N (%) 1 Nº (%) I II III Campylobacter jejuni 32 22.7 17 (53.1) 2 14 (43.8) 1 (3.1) 32 (100) 2 Campylobacter coli 12 8.5 3 (25.0) 3 9 (75.0) 12 (100) 3 TOTAL 44 31.2 1 Percentage in relation to all the samples studied; 2 Percentage in relation to all C. jejuni isolated; 3 Percentage in relation to all C. coli isolated. 2

None of the strains showed resistance to chloramphenicol, erythromycin, gentamicin and tetracycline. Resistance to ampicillin and ciprofloxacin was detected in 4 (9.1%) and 6 (13.6%) respectively. All the ampicillin resistant strains were beta lactamase producers (Table 2). Table 2. Minimal inhibitory concentrations (MICs) of 44 Campylobacter strains isolated from healthy dog feces to six antimicrobial agents using the E-test method. Antibiotic MIC 50 MIC 90 Range Resistance (%) Ampicillin 3.0 8.0 0.25-32.0 9.1* Erythromycin 0.38 1.5 0.047-6.0 0 Gentamicin 0.75 4.0 0.25-6.0 0 Chloramphenicol 0.75 2.0 0.016-3.0 0 Ciprofloxacin 0.032 0.125 0.047 - >32 13.6 Tetracycline 0.064 0.38 0.016-1.0 0 *beta lactamase producer strains. DISCUSSION The recovery rate of Campylobacter from dogs in this study (31.2%) was higher than that obtained by us (21.9%) in a previous survey in Chile [4], as well as than those obtained by others in Argentina (17%) [15], Peru (25%) [11] and Brazil (27.7%) [18]. However, the present recovery rate of Campylobacter was lower than that obtained in Ireland (41.5%) [1], Barbados (46.9%) [24] and also in two other studies conducted by our group in children and animals in Chile (42.5% ; 58.3%) [8,10]. In this study, the predominant Campylobacter species was C. jejuni followed by C. coli. This distribution of species seems to be normal because, as reported in other studies, C. jejuni is always more frequent than C. coli in dogs [3,4,6-8,10,11,15]. As shown in Table 1, three of the four biotypes described by Lior [14] for C. jejuni and the two biotypes described for C. coli were found. Among C. jejuni isolates, biotype I was the most frequent one (53.1%) followed by biotypes II (43.8%) and III (3.1%). C. coli biotype II was more frequently isolated (75%) than biotype I (25%). Similar results were previously reported by our group in pet dogs but, in stray dogs, all the biotypes described by Lior [14] were found [4]. This difference could be due to the fact that stray dogs may be more exposed to environmental sources of Campylobacter than household pets are. The Campylobacter isolation rate for asymptomatic dogs reported here is relatively high and should to be considered as not negligible; rather it may provide an epidemiological insight about the risk of zoonotic infection for individuals maintaining contact with dogs, especially for children. Evans [2] and Mahdi-Saed et al. [17] reported that direct contact with pets is a risk factor for acquiring campylobacteriosis in children, which has also observed in Latin-American countries [6-8]. In the present study, no strain was found to be resistant to chloramphenicol, tetracycline, gentamicin and erythromycin. The latter is the drug of choice to treat Campylobacter enteritis and gentamicin, the antimicrobial agent indicated to treat extra-intestinal infections due to Campylobacter [16,19,20,25]. In Brazil, Modolo et al. [19] did not find resistance for erythromycin, gentamycin, enrofloxacin and chloramphenicol, but they found high resistance to tetracycline. From the 44 strains studied, four (9.1%) were resistante to ampicillin. All of them were able to produce ß-lactamase. The presence of Campylobacter ß-lactamase producer strains is known in different countries and was reported for the first time in Chile by Fernández et al. [9]. Over the past decade, resistance to quinolones in Campylobacter has been increasingly reported in strains isolated from both human beings and animals, especially from animals related to husbandry [23]. The 13.9% of resistant strains to ciprofloxacin found in this study probably could be a reflection of the spread of these kind of strains from food-producing animals and the environment to human pets. Given that dogs have been identified as a potential source of human infections [2,7,10,12,15,17,19,25], exposure to animals carrying fluoroquinolone-resistant microorganisms could be another risk factor for acquiring fluoroquinoloneresistant Campylobacter strains. 3

CONCLUSION This study provides an insight into the intestinal carriage of Campylobacter jejuni and C. coli biotypes in healthy dogs and their antimicrobial susceptibility behavior in Southern Chile. Due to the epidemiological importance of dogs as reservoirs and to the presence of Campylobacter strains resistant to ampicillin and ciprofloxacin, it is necessary to submit these pets to periodic monitoring for Campylobacter and their antimicrobial resistance. SOURCE AND MANUFACTURER 1 biomérieux, Marcy/Etoile, France. Acknowledgments. Thanks are due to Dr. Hans Richter (Institute of Anatomy, Histology and Pathology, Universidad Austral de Chile) for their advices and critical review. This work received financial support from Grants FONDECYT 1030245 and 1110202 and SE-1-2009 DID-UACH. Declaration of interest. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. REFERENCES 1 Acke E., Whyte P., Jones B.R., McGill K., Collins J.D. & Fanning S. 2006. Prevalence of thermophilic Campylobacter species in cats and dogs in two animal shelters in Ireland. Veterinary Record. 158(2): 51-54. 2 Evans S.J. 1993. The seasonality of canine births and human campylobacteriosis: a hypothesis. Epidemiology & Infection. 110(2): 267-272. 3 Fernández H. & Hitschfeld M. 2009. Occurrence of Campylobacter jejuni and Campylobacter coli and their biotypes in beef and dairy cattle from the South of Chile. Brazilian Journal of Microbiology. 40(3): 450-454. 4 Fernández H. & Martin R. 1991. Campylobacter intestinal carriage among stray and pet dogs. Revista de Saúde Pública. 25(6): 473-475. 5 Fernández H. 1992. Increase of Campylobacter isolation rates using an enrichment medium. Revista de Microbiologia. 23(1): 5-7. 6 Fernández H. 1992. Thermotolerant Campylobacter species associated with human diarrhea in Latin America. Journal of the Brazilian Association for the Advancement of Science. 44(1): 39-43. 7 Fernández H. 2011. Campylobacter and campylobacteriosis: a view from South America. Revista Peruana de Medicina Experimental y Salud Pública. 28(1): 121-127. 8 Fernández H., Kahler K., Salazar R. & Ríos M. 1994. Prevalence of thermotolerant species of Campylobacter and their biotypes in children and domestic birds and dogs in Southern Chile. Revista do Instituto de Medicina Tropical. 36(5): 433-436. 9 Fernández H., Mansilla M. & González V. 2000. Antimicrobial Susceptibility of Campylobacter jejuni subsp. jejuni Assessed by E-test and Double Dilution Agar Method in Southern Chile. Memórias do Instituto Oswaldo Cruz. 95(2): 247-249. 10 Fernández H., Vera F. & Villanueva M.P. 2007. Arcobacter and Campylobacter species in birds and mammals from Southern Chile. Archivos de Medicina Veterinaria. 39(2): 163-165. 11 Grados O., Bravo N., Black R.E. & Butzler J.P. 1988. Paediatric Campylobacter diarrhoea from household exposure to live chickens in Lima, Peru. Bulletin of the World Health Organization. 66(3): 369-374. 12 Humphrey T., O Brien S. & Madsen M. 2007. Campylobacters as zoonotic pathogens: A food production perspective. International Journal of Food Microbiology. 117(3): 237-257. 13 Jones R. N. & Dudley M.N. 1997. Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: Analysis of the correlations between in vitro test results and clinical response. Diagnostic Microbiology and Infectious Disease. 28(1): 5-18. 14 Lior H. 1984. New, extended biotyping scheme for Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis. Journal of Clinical Microbiology. 20(4): 636-640. 15 López C. M., Giacoboni G., Agostinia A., Corneroa F.J., Tellechea D.M. & Trinidad J.J. 2002. Thermotolerant campylobacters in domestic animals in a defined population in Buenos Aires, Argentina. Preventive Veterinary Medicine. 55(3): 193-200. 16 Mackiw E., Korsak D., Rzewuska K., Tomczuk K. & Rozynek E. 2012. Antibiotic resistance in Campylobacter jejuni and Campylobacter coli isolated from food in Poland. Food Control. 23(2): 297-301. 4

17 Mahdi-Saed A. M., Harris N.V. & DiGiacomo R.F. 1993. The role of exposure to animals in the etiology of Campylobacter jejuni/coli enteritis. American Journal of Epidemiology. 137(1): 108-114. 18 Mamizuka E., Schwartz D., Borges M. & Kuribayashi M. 1993. Isolation of Campylobacter jejuni from dogs with diarrhea. Revista de Microbiologia. 24(2): 84-87. 19 Modolo J.R., Giuffrida R. & Lopes C.A.M. 2003. Antimicrobial susceptibility of 51 Campylobacter strains isolated from diarrheic and diarrhea-free dogs. Arquivos do Instituto Biológico. 70(3): 283-286. 20 Moore J.E., Corcoran D., Dooley J.S.G., Fanning S., Lucey B., Matsuda M., Mcdowell D.A., Mégraud F., Millar B.C., O Mahony R., O Riordan L., O Rourke M., Rao J.R., Rooney P.J., Sails A. & Whyte P. 2005. Campylobacter. Veterinary Research. 36(3): 351-382. 21 Newell D.G. 1982. Campylobacter: epidemiology, pathogenesis and biochemistry. Lancaster: MTP Pres Ltd., 307p. 22 Otth L., Wilson M., Cancino R. & Fernández H. 2004. In vitro susceptibility of Arcobacter butzleri to six antimicrobial drugs. Archivos de Medicina Veterinaria. 36 (2): 207-210. 23 Smith J.L. & Fratamico P.M. 2010. Fluoroquinolone Resistance in Campylobacter. Journal of Food Protection. 73(6): 1141-1152. 24 Workman S.N., Mathison G.E. & Lavoie M.C. 2005. Pet Dogs and Chicken Meat as Reservoirs of Campylobacter spp. in Barbados. Journal of Clinical Microbiology. 43(6): 2642-2650. 25 World Health Organization. 2001. The increasing incidence of human campylobacteriosis. Report and Proceedings of a WHO Consultation of Experts. Copenhagen. WHO/CDS/CSR/APH/2000.4. www.ufrgs.br/actavet 1100 5